Role of heme oxygenase-1 and its reaction product, carbon monoxide, in manifestation of breast cancer stem cell-like properties: Notch-1 as a putative target

References

• Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5:275–284.
   PubMed Web of Science ®Google Scholar
• Li Y, Laterra J. Cancer stem cells: distinct entities or dynamically regulated phenotypes? Cancer Res. 2012;72:576–580.
   PubMed Web of Science ®Google Scholar
• Koch U, Radtke F. Notch and cancer: a double-edged sword. Cell Mol Life Sci. 2007;64:2746–2762.
   PubMed Web of Science ®Google Scholar
• Miele L, Osborne B. Arbiter of differentiation and death: notch signaling meets apoptosis. J Cell Physiol. 1999;181:393–409.
   PubMed Web of Science ®Google Scholar
• Bolós V, Mira E, Martínez-Poveda B, et al. Notch activation stimulates migration of breast cancer cells and promotes tumor growth. Breast Cancer Res. 2013;15:R54.
   PubMed Web of Science ®Google Scholar
• Zang S, Chen F, Dai J, et al. RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer. Oncol Rep. 2010;23:893–899.
   PubMed Web of Science ®Google Scholar
• Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284:770–776.
   PubMed Web of Science ®Google Scholar
• Kadesch T. Notch signaling: a dance of proteins changing partners. Exp Cell Res. 2000;260:1–8.
   PubMed Web of Science ®Google Scholar
• Farnie G, Clarke RB. Mammary stem cells and breast cancer - role of Notch signalling. Stem Cell Rev. 2007;3:169–175.
   PubMed Web of Science ®Google Scholar
• Reedijk M, Odorcic S, Chang L, et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005;65:8530–8537.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Shen S, Zhou Y, et al. NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells. Onco Targets Ther. 2016;9:6865–6871.
   PubMed Web of Science ®Google Scholar
• Xie X, Kaoud TS, Edupuganti R, et al. C-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun. Oncogene. 2017;36:2599–2608.
   PubMed Web of Science ®Google Scholar
• Jang YY, Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood. 2007;110:3056–3063.
   PubMed Web of Science ®Google Scholar
• Paul MK, Bisht B, Darmawan DO, et al. Dynamic changes in intracellular ROS levels regulate airway basal stem cell homeostasis through Nrf2-dependent Notch signaling. Cell Stem Cell. 2014;15:199–214.
   PubMed Web of Science ®Google Scholar
• Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458:780–783.
   PubMed Web of Science ®Google Scholar
• Skvortsova I, Debbage P, Kumar V, et al. Radiation resistance: cancer stem cells (CSCs) and their enigmatic pro-survival signaling. Semin Cancer Biol. 2015;35:39–44.
   PubMed Web of Science ®Google Scholar
• Chen C, Liu Y, Liu Y, et al. The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells. Cell Cycle. 2009;8:1158–1160.
   PubMed Web of Science ®Google Scholar
• González-Bártulos M, Aceves-Luquero C, Qualai J, et al. Pro-oxidant activity of amine-pyridine-based iron complexes efficiently kills cancer and cancer stem-like cells. PLoS One. 2015;10:e0137800.
   PubMed Web of Science ®Google Scholar
• Venugopal R, Jaiswal AK. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene. 1998;17:3145–3156.
   PubMed Web of Science ®Google Scholar
• Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1029–L1037.
   PubMed Web of Science ®Google Scholar
• Kärkkäinen V, Pomeshchik Y, Savchenko E, et al. Nrf2 regulates neurogenesis and protects neural progenitor cells against Abeta toxicity. Stem Cells. 2014;32:1904–1916.
   PubMed Web of Science ®Google Scholar
• Cai C, Teng L, Vu D, et al. The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. J Biol Chem. 2012;287:33720–33732.
   PubMed Web of Science ®Google Scholar
• Dey S, Sayers CM, Verginadis II, et al. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. J Clin Invest. 2015;125:2592–2608.
   PubMed Web of Science ®Google Scholar
• Nuhn P, Künzli BM, Hennig R, et al. Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo. Mol Cancer. 2009;8:37.
   PubMed Web of Science ®Google Scholar
• Wu W, Ma D, Wang P, et al. Potential crosstalk of the interleukin-6-heme oxygenase-1-dependent mechanism involved in resistance to lenalidomide in multiple myeloma cells. FEBS J. 2016;283:834–849.
   PubMed Web of Science ®Google Scholar
• Loboda A, Jozkowicz A, Dulak J. HO-1/CO system in tumor growth, angiogenesis and metabolism – Targeting HO-1 as an anti-tumor therapy. Vascul Pharmacol. 2015;74:11–22.
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983–3988.
   PubMed Web of Science ®Google Scholar
• Alfarouk KO, Stock CM, Taylor S, et al. Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int. 2015;15:71.
   PubMed Web of Science ®Google Scholar
• Boesch M, Sopper S, Zeimet AG, et al. Heterogeneity of cancer stem cells: rationale for targeting the stem cell niche. Biochim Biophys Acta. 2016;1866:276–289.
   PubMed Web of Science ®Google Scholar
• Ogasawara MA, Zhang H. Redox regulation and its emerging roles in stem cells and stem-like cancer cells. Antioxid Redox Signal. 2009;11:1107–1122.
   PubMed Web of Science ®Google Scholar
• Shi X, Zhang Y, Zheng J, et al. Reactive oxygen species in cancer stem cells. Antioxid Redox Signal. 2012;16:1215–1228.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang T, Dong Q, et al. Redox homeostasis: the linchpin in stem cell selfrenewal and differentiation. Cell Death Dis. 2013;4:e537.
   PubMed Web of Science ®Google Scholar
• Ryoo IG, Choi BH, Kwak MK. Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells. Oncotarget. 2015;6:8167–8184.
   PubMed Web of Science ®Google Scholar
• Ryoo IG, Kim G, Choi BH, et al. Involvement of NRF2 signaling in doxorubicin resistance of cancer stem cell-enriched Colonospheres. Biomol Ther (Seoul). 2016;24:482–488.
   PubMed Web of Science ®Google Scholar
• Mizuno T, Suzuki N, Makino H, et al. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species. Gynecol Oncol. 2015;137:299–305.
   PubMed Web of Science ®Google Scholar
• Li D, Masiero M, Banham AH, et al. The notch ligand JAGGED1 as a target for anti-tumor therapy. Front Oncol. 2014;4:254.
   PubMedGoogle Scholar
• Li L, Zhao F, Lu J, et al. Notch-1 signaling promotes the malignant features of human breast cancer through NF-kappaB activation. PLoS One. 2014;9:e95912.
   PubMed Web of Science ®Google Scholar
• Grudzien P, Lo S, Albain KS, et al. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Anticancer Res. 2010;30:3853–3867.
   PubMed Web of Science ®Google Scholar
• Boo L, Ho WY, Mohd Ali N, et al. Phenotypic and microRNA transcriptomic profiling of the MDA-MB-231 spheroid-enriched CSCs with comparison of MCF-7 microRNA profiling dataset. Peer J. 2017;5:e3551.
   PubMed Web of Science ®Google Scholar
• Busserolles J, Megías J, Terencio MC, et al. Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway. Int J Biochem Cell Biol. 2006;38:1510–1517.
   PubMed Web of Science ®Google Scholar
• South AP, Cho RJ, Aster JC. The double-edged sword of Notch signaling in cancer. Semin Cell Dev Biol. 2012;23:458–464.
   PubMed Web of Science ®Google Scholar
• Nemeth Z, Csizmadia E, Vikstrom L, et al. Alterations of tumor microenvironment by carbon monoxide impedes lung cancer growth. Oncotarget. 2016;7:23919–23932.
   PubMedGoogle Scholar
• Palomero T, Lim WK, Odom DT, et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA. 2006;103:18261–18266.
   PubMed Web of Science ®Google Scholar
• Sharma VM, Calvo JA, Draheim KM, et al. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol. 2006;26:8022–8031.
   PubMed Web of Science ®Google Scholar
• Palomero T, Ferrando A. Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas. Clin Cancer Res. 2008;14:5314–5317.
   PubMed Web of Science ®Google Scholar
• Qi R, An H, Yu Y, et al. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res. 2003;63:8323–8329.
   PubMed Web of Science ®Google Scholar
• Franklin RA, Liao W, Sarkar A, et al. The cellular and molecular origin of tumor-associated macrophages. Science. 2014;344:921–925.
   PubMed Web of Science ®Google Scholar
• Bhola NE, Jansen VM, Koch JP, et al. Treatment of triple-negative breast cancer with TORC1/2 inhibitors sustains a drug-resistant and Notch-dependent cancer stem cell population. Cancer Res. 2016;76:440–452.
   PubMed Web of Science ®Google Scholar